Literature DB >> 30280261

Septic Encephalopathy.

Chiara Robba1,2, Ilaria Alice Crippa2,3, Fabio Silvio Taccone4,5.   

Abstract

PURPOSE OF THE REVIEW: To discuss the diagnostic approach to patients with septic encephalopathy as well as the need for specific neuro-monitoring and the perspectives on future therapeutic approaches in this setting. RECENT
FINDINGS: Most of data-concern experimental studies evaluating the pathophysiology of septic encephalopathy. A combination of neurodegenerative pathways with neurovascular injury is the cornerstone for the development of such complication and the long-term neurological sequelae among survivors. Septic encephalopathy is a common complication in septic patients. Clinical presentation may range from mild confusion and disorientation to convulsions and deep coma. The diagnosis of septic encephalopathy is made difficult by the lack of any specific clinical and non-clinical feature, in particular among sedated patients in whom neurological examination is unreliable. In spite of the high mortality rate associated with this condition, there is no prophylactic or targeted therapy to reduce or minimize brain damage in septic patients and clinical management is limited to the treatment of the underlying infection.

Entities:  

Keywords:  Cognitive dysfunction; Encephalopathy; Outcome; Sepsis

Mesh:

Year:  2018        PMID: 30280261     DOI: 10.1007/s11910-018-0895-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  81 in total

1.  Cerebrospinal fluid in critical illness.

Authors:  B Venkatesh; P Scott; M Ziegenfuss
Journal:  Crit Care Resusc       Date:  2000-03       Impact factor: 2.159

2.  Magnetic resonance imaging abnormalities with septic encephalopathy.

Authors:  P F Finelli; D F Uphoff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

3.  Cerebral net exchange of large neutral amino acids after lipopolysaccharide infusion in healthy humans.

Authors:  Ronan Mg Berg; Sarah Taudorf; Damian M Bailey; Carsten Lundby; Fin Stolze Larsen; Bente Klarlund Pedersen; Kirsten Møller
Journal:  Crit Care       Date:  2010-02-11       Impact factor: 9.097

4.  Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients.

Authors:  Pratik Pandharipande; Bryan A Cotton; Ayumi Shintani; Jennifer Thompson; Brenda Truman Pun; John A Morris; Robert Dittus; E Wesley Ely
Journal:  J Trauma       Date:  2008-07

5.  Continuous electroencephalography in the medical intensive care unit.

Authors:  Mauro Oddo; Emmanuel Carrera; Jan Claassen; Stephan A Mayer; Lawrence J Hirsch
Journal:  Crit Care Med       Date:  2009-06       Impact factor: 7.598

6.  Sepsis is associated with altered cerebral microcirculation and tissue hypoxia in experimental peritonitis.

Authors:  Fabio Silvio Taccone; Fuhong Su; Cathy De Deyne; Ali Abdellhai; Charalampos Pierrakos; Xinrong He; Katia Donadello; Olivier Dewitte; Jean-Louis Vincent; Daniel De Backer
Journal:  Crit Care Med       Date:  2014-02       Impact factor: 7.598

Review 7.  Brain perfusion in sepsis.

Authors:  Fabio Silvio Taccone; Sabino Scolletta; Federico Franchi; Katia Donadello; Mauro Oddo
Journal:  Curr Vasc Pharmacol       Date:  2013-03-01       Impact factor: 2.719

8.  Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group.

Authors:  C L Sprung; P N Peduzzi; C H Shatney; R M Schein; M F Wilson; J N Sheagren; L B Hinshaw
Journal:  Crit Care Med       Date:  1990-08       Impact factor: 7.598

9.  Hyperglycaemia and apoptosis of microglial cells in human septic shock.

Authors:  Andrea Polito; Jean-Philippe Brouland; Raphael Porcher; Romain Sonneville; Shidasp Siami; Robert D Stevens; Céline Guidoux; Virginie Maxime; Geoffroy Lorin de la Grandmaison; Fabrice C Chrétien; Françoise Gray; Djillali Annane; Tarek Sharshar
Journal:  Crit Care       Date:  2011-05-25       Impact factor: 9.097

10.  Selective Activation of Basal Forebrain Cholinergic Neurons Attenuates Polymicrobial Sepsis-Induced Inflammation via the Cholinergic Anti-Inflammatory Pathway.

Authors:  Qian Zhai; Dengming Lai; Ping Cui; Rui Zhou; Qixing Chen; Jinchao Hou; Yunting Su; Libiao Pan; Hui Ye; Jing-Wei Zhao; Xiangming Fang
Journal:  Crit Care Med       Date:  2017-10       Impact factor: 7.598

View more
  18 in total

Review 1.  Brain ultrasonography: methodology, basic and advanced principles and clinical applications. A narrative review.

Authors:  Chiara Robba; Alberto Goffi; Thomas Geeraerts; Danilo Cardim; Gabriele Via; Marek Czosnyka; Soojin Park; Aarti Sarwal; Llewellyn Padayachy; Frank Rasulo; Giuseppe Citerio
Journal:  Intensive Care Med       Date:  2019-04-25       Impact factor: 17.440

2.  The use of automated pupillometry to assess cerebral autoregulation: a retrospective study.

Authors:  Armin Quispe Cornejo; Carla Sofía Fernandes Vilarinho; Ilaria Alice Crippa; Lorenzo Peluso; Lorenzo Calabrò; Jean-Louis Vincent; Jacques Creteur; Fabio Silvio Taccone
Journal:  J Intensive Care       Date:  2020-07-31

3.  Interleukin-1β Modulates Synaptic Transmission and Synaptic Plasticity During the Acute Phase of Sepsis in the Senescence-Accelerated Mouse Hippocampus.

Authors:  Koji Hoshino; Yuka Uchinami; Yosuke Uchida; Hitoshi Saito; Yuji Morimoto
Journal:  Front Aging Neurosci       Date:  2021-02-10       Impact factor: 5.750

4.  Early Axonal Injury and Delayed Cytotoxic Cerebral Edema are Associated with Microglial Activation in a Mouse Model of Sepsis.

Authors:  Diana Pang; Yijen L Wu; Alicia M Alcamo; Jessica Cummings; Valentina Di Caro; Thomas Walko; Victor Hsue; Robert S B Clark; Ashok Panigrahy; Patrick M Kochanek; Rajesh K Aneja
Journal:  Shock       Date:  2020-08       Impact factor: 3.533

5.  Imbalanced Subthreshold Currents Following Sepsis and Chemotherapy: A Shared Mechanism Offering a New Therapeutic Target?

Authors:  Mark M Rich; Stephen N Housley; Paul Nardelli; Randall K Powers; Timothy C Cope
Journal:  Neuroscientist       Date:  2020-12-21       Impact factor: 7.235

6.  Ultrasonic Assessment of Optic Nerve Sheath Diameter in Patients at Risk of Sepsis-Associated Brain Dysfunction: A Preliminary Report.

Authors:  Piotr F Czempik; Jakub Gąsiorek; Aleksandra Bąk; Łukasz J Krzych
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

7.  Multimodal non-invasive assessment of intracranial hypertension: an observational study.

Authors:  Chiara Robba; Selene Pozzebon; Bedrana Moro; Jean-Louis Vincent; Jacques Creteur; Fabio Silvio Taccone
Journal:  Crit Care       Date:  2020-06-26       Impact factor: 9.097

8.  Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants.

Authors:  Xue-Lin Li; Jinming Han; Zhong-Rui Yan; Bing-Wei Zhang; Hai-Yang Wang
Journal:  J Neurovirol       Date:  2021-07-05       Impact factor: 2.643

9.  Early Effects of Passive Leg-Raising Test, Fluid Challenge, and Norepinephrine on Cerebral Autoregulation and Oxygenation in COVID-19 Critically Ill Patients.

Authors:  Chiara Robba; Antonio Messina; Denise Battaglini; Lorenzo Ball; Iole Brunetti; Matteo Bassetti; Daniele R Giacobbe; Antonio Vena; Nicolo' Patroniti; Maurizio Cecconi; Basil F Matta; Xiuyun Liu; Patricia R M Rocco; Marek Czosnyka; Paolo Pelosi
Journal:  Front Neurol       Date:  2021-06-16       Impact factor: 4.003

10.  Stanniocalcin 1 Inhibits the Inflammatory Response in Microglia and Protects Against Sepsis-Associated Encephalopathy.

Authors:  Sandra Bonfante; Larissa Joaquim; Maria Eduarda Fileti; Amanda Della Giustina; Mariana Pereira de Souza Goldim; Lucinéia Gainski Danielski; Evandro Cittadin; Raquel Jaconi De Carli; Bianca Xavier de Farias; Nicole Alessandra Engel; Naiana da Rosa; Jucélia Jeremias Fortunato; Vijayasree Giridharan; Giselli Scaini; Gislaine Tezza Rezin; Jaqueline Generoso; Rafael Mariano de Bitencourt; Silvia Terra; Tatiana Barichello; Fabricia Petronilho
Journal:  Neurotox Res       Date:  2020-10-06       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.